AXNX News and Press, Axonics Modulation Technologies Inc. From 09/24/19

One-year Pivotal Study Results from ARTISAN-SNM to be Presented at Plenary Session Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the...

Axonics Modulation Technologies (NASDAQ: AXNX ) revealed on Monday (September 9) that the US Food and Drug Administration has given the company seal of approval for its rechargeable sacral neuromodulation (SNM) device. Called the Axonics r-SNM® System, the rechargeable devic...

Company to host conference call and webcast at 9:00 am EDT Today Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral neuromodulation (“SNM”) device for the t...

Nuvectra Corporation (NASDAQ: NVTR ) is a medical device company founded in 2008 that went public in March 2016. NVTR’s flagship product, Algovita, is a neurostimulator that is FDA approved for the treatment of chronic pain of the trunk (human torso) and limbs (reimbursable under exis...

Correvio Pharma (NASDAQ: CORV ) initiated with Overweight rating and $6 (193% upside) price target at Cantor Fitzgerald. More news on: Correvio Pharma Corp., InMode Ltd., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more ...

Axonics Modulation Technologies, Inc. (AXNX) Q2 2019 Results Earnings Conference Call August 05, 2019, 4:30 pm ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - Presi...

Axonics Modulation Technologies (NASDAQ: AXNX ): Q2 GAAP EPS of -$0.68 misses by $0.19 . More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction, reported today financial results for the sec...

AEIS , AEL , ANSS , APLE , APU , ATSG , AVID , AWR , AXNX , BHF , BKD , BKH , BWXT , CAR , CBPO , CBT , CDEV , CLR , COHU , CSOD , CXW , CYH , CZR , DEI , DIOD , DOOR , DRH , EVBG , FRPT , FRTA , GPRE , HIIQ , HLIO , HPR , IFF , IPAR , ITRI , IVC , KLA...

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing a novel implantable Sacral Neuromodulation (“SNM”) device for the treatment of urinary and bowel dysfunction , today announced completion of 1-year follo...